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Abstract Characterization and localization of leptin binding 
sites were investigated in rat kidneys using [125I]leptin as a 
ligand. [125I]Leptin specific binding was found in high amounts in 
rat renomedullary membranes. This binding was specific, 
saturable, time-dependent (Kobs - 0.055 ± 0.008 min ') and the 
dissociation of receptor-bound ligand was slowly reversible 
(A" i = 0.048 ± 0.013 min_ 1) . From saturation experiments, a 
single class of high-affinity binding sites for leptin was identified 
with an apparent KA of 0.57 ± 0.14 nM and a £ m a x of 45 ± 10 
fmol/mg protein. |125I]Leptin binding was inhibited in a dose-
dependent manner by cold leptin and was highly selective since 
not displaceable by a number of other hormones or peptides. 
Autoradiographic experiments performed on adult rat kidney 
sections showed the intense presence of [125I]leptin receptors only 
in specific areas of the renal inner medulla and also consistent 
labeling associated with vascular structures in the cortico-
medullary region. The study of the postnatal developmental 
expression of leptin receptors in the kidney showed very low 
expression during the early postnatal period (8-21 days). Full 
expression of leptin sites was achieved at about 30 days and 
remained stable throughout adulthood (60 days and upwards). 
Moreover, in vivo administration of leptin (0.5 mg/kg i.p.) 
induced a significant and rapid diuretic effect in normally 
hydrated conscious rats. Thus, these data constitute the first 
characterization and mapping of I125I]leptin specific binding sites 
in the rat kidney and raise the possibility of a renal control by 
leptin. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Leptin, the ob-gene product, is a recently isolated 16 k D a 
hormone highly conserved among vertebrates, exclusively syn-
thesized and secreted by adipose tissue into the blood stream 
[1-4]. In obese leptin-deficient ob/ob mice, this hormone was 
initially identified as a key satiety signal able to reduce food 
intake, fat tissue, hyperglycemia and hyperinsulinemia pre-
sumably by interaction with specific receptors expressed at a 
high level in the hypothalamus [5]. Thus, this factor was ex-
pected to be a central regulator in controlling body weight 
and treating obesity. However, with the exception of the ob/ 
ob mice strain, circulating leptin plasma levels are in general 
elevated in obesity, suggesting that leptin resistance rather 
than leptin deficiency seems a common feature of obesity in 
human [6-8], primate [4] and and in most models of rodent 
obesity [9]. In fact, it is a defect in the leptin receptor which 
causes obesity. The leptin receptor has been cloned and up to 
now, various alternatively spliced forms of the leptin receptor 
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m R N A (at least 6 in mice) have been discovered in several 
species including mice, rat and human [10-14]. 
While most attention of the biological effects of leptin have 
been focused on the hypothalamus, the m R N A of several 
leptin receptor isoforms—including the leptin receptor long 
transcript, identified as the functional receptor—has also 
been found, with a different pat tern of distribution, in a num-
ber of non-neuronal tissues such as the lung, liver, kidney, 
heart, reproductive organs and fat [10-14]. These preliminary 
findings could implicate leptin in pathways other than energy 
metabolism and suggest that leptin receptors, when expressed, 
could mediate a variety of direct peripheral actions. 
In an at tempt to determine the role of leptin in the regu-
lation of the renal function, the purpose of the present study 
was to investigate the expression, characterization and distri-
bution of leptin receptors in the rat kidney using [125I]leptin as 
a ligand. By autoradiographic techniques, the developmental 
expression of leptin receptors was also examined to gain in-
formation on the role of this hormone in renal cellular growth 
and organ development. Finally, the functional role of leptin 
in the kidney was further investigated by studying its effect on 
diuresis after in vivo administration in rats. 
2. Materials and methods 
2.1. Materials 
2.1.1. Chemicals. Recombinant murine leptin was obtained from 
Pepro Tech Inc. (Rocky Hill, NJ). Bacitracin, leukemia inhibitory 
factor (LIF), insulin, interleukin-6 (IL-6), granulocyte-colony stimu-
lating factor (G-CSF), and various peptides were from Sigma Chem-
ical Co. (L'isle d'Abeau, France). Bovine serum albumin was obtained 
from Biosepra (Paris, France). All other chemicals were from Merck-
Clevenot (Nogent sur Marne, France) or Prolabo (Paris, France). 
The [125I]murine leptin (2000 Ci/mmol) was kindly provided by 
New England Nuclear (Les Ulis, France). 
2.1.2. Animals. Male Sprague-Dawley rats were obtained at differ-
ent ages (8, 21, 30, 60 and 84 days; b.wt. 18, 50, 90, 280 and 420 g, 
respectively) from Charles River Breeding Laboratories, Inc. (Saint-
Aubin les Elbeuf, France). The animals were housed in a tempera-
ture-, humidity- and light-controlled room (12-h light/dark cycle) and 
allowed free access to water and standard rat chow. All protocols 
performed in this study have been approved by the Animal Care 
and Use Committee of Sanofi Recherche. 
2.2. Membrane preparations 
Male Sprague-Dawley rats (60 days old, b.wt. 250-300 g) were 
killed by decapitation and the kidneys were immediately removed. 
The two anatomic structures, cortex and medulla (i.e. inner-outer 
medulla and papilla) were rapidly dissected and collected in ice-cold 
saline, 1 mM EDTA, pH 7.5, for membrane preparations. Membranes 
resulting from each structure were prepared by the method of Stassen 
et al. [15] and stored as aliquots in liquid nitrogen (5 mg protein/ml). 
Protein concentration was determined by the method of Bradford 
using bovine serum albumin as a standard [16]. 
2.3. Binding assays 
Rat kidney membranes (50-100 ug/ml) were incubated for 90 min 
at 20°C in a 200 JJ.1 of Krebs-Ringer medium (pH 7.4) containing 20 
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mM HEPES, 1% (w/v) bovine serum albumin, 300 ng/ml bacitracin 
and 60 pM [125I]leptin. The incubation was stopped by adding 4 ml of 
ice-cold buffer and the contents of the assay tubes were filtered rapidly 
through Whatman GF/C filters, then rinsed with 8 ml of ice-cold wash 
buffer. The radioactivity of the filter was counted in an LKB multiwell 
gamma counter. Non-specific binding was determined by incubating 
with 0.3 uM c°ld leptin. Competition studies were performed on 
medullary membranes with 60 pM of [125I]leptin in the presence of 
increasing concentrations of unlabeled leptin (0.003, 0.01, 0.03, 0.1, 
0.3, 0.6, 1, 3, 6, 10, 30, and 100) or of various concentrations of 
peptides or hormones. The association constant was determined by 
measuring the binding of 60 pM [126I]leptin to the medullary mem-
branes at different times (3, 6, 9, 12, 15, 20, 30, 45, 60, 75, 90, 120, 
150, 180, 240, 270, and 330 min) and dissociation was initiated at 90 
min by adding 1 (iM unlabeled leptin. 
The IC50 value was defined as the concentration of inhibitor re-
quired to obtain 50% inhibition of the specific binding. Inhibition 
constant (X;) values were calculated from the IC50 values using the 
Cheng and Prusoff equation [17]. Data for equilibrium binding [ap-
parent equilibrium dissociation constant (KA), maximum binding den-
sity (Bmax)], competition experiment [IC50, Hill coefficient («H)], and 
kinetic constants [apparent association rate constant (Kohs), apparent 
dissociation rate constant (K-i)], were analyzed using an interactive 
non-linear regression program [18]. 
2.4. Autoradiography 
Male Sprague-Dawley rats at various ages (8, 21, 30, 60 and 84 
days old) were decapitated and the kidneys were rapidly removed and 
frozen in isopentane at —40°C. Serial sections (16 urn) were cut in a 
cryostat microtome and thaw-mounted into chrom-alum gelatin-
coated glass slides (gelatin 1%, chrom-alum 0.05%). Sections were 
stored at —80°C until use. Slide-mounted sections (3-10 sections/slide 
according to the size of the kidney), brought to room temperature, 
were preincubated for 15 min in the binding buffer (Krebs-Ringer 
medium; pH 7.4, containing 20 mM HEPES, 1% (w/v) bovine serum 
albumin, 300 |a,g/ml bacitracin). Incubation was carried out for 90 min 
at room temperature in the incubating medium in the presence of 
about 40 pM [125I]leptin. Non-specific binding was determined by 
incubating additional adjacent rat kidney sections under the same 
conditions and in the presence of 0.3 uM unlabeled leptin. After 
incubation, the slides were washed 3 times for 10 min each in ice-
cold buffer, dipped briefly in distilled water, and dried for 60 min 
under a stream of cold air [19,20]. The slide-mounted sections were 
exposed to X-ray Hyperfilm-[3H] (Amersham, Les Ulis, France) for 
7 days at — 20°C to generate autoradiographic images. 
2.5. Diuretic activity of leptin in conscious rats in vivo 
Leptin (0.5 or 1 mg/kg) was administered intraperitonealy (1 ml/kg) 
to conscious normally hydrated or to water-loaded (25 ml bidistilled 
water/kg by gavage just before starting the experiment) rats (250 g 
b.wt.). The animals were then housed individually in metabolic cages 
without food and water and urines were collected for 6 h with indi-
vidual measures of urine volume at 0.5, 1, 2, 4 and 6 h. The effect of 
leptin on urine osmolality was studied at each 2-h period for 6 h 
following leptin or vehicle administration. Urine osmolality was meas-
ured with a freezing point depression osmometer (model M85501, 
Roebling, Bioblock Scientific, France). 
Control rats received the same volume of bidistilled water. Urine 
volume of the control and treated groups was compared using the 
non-parametric test of Mann-Whittney corrected by Bonferroni using 
RS/1 software. Statistical significance of leptin effect on miction la-
tency was analyzed according to a Kruskal-Wallis' test using StatxAct 
software. The level of significance was taken as P < 0.05. Results are 
means ± SEM. 
3. Results 
3.1. Characterization of f125'Ij'leptin binding sites in rat kidney 
membranes 
In preliminary experiments, binding sites of [125I]leptin were 
studied in renal membrane preparations resulting from two 
main anatomic structures of the adult rat kidney, the cortex 
and the medulla. Specific binding was almost undetectable in 
cortical preparations whereas significant amounts of specific 
labeling were found in medullary membranes as a function of 
the protein content in the assay (not shown). The time-course 
of association (Fig. 1) showed that specific binding of 
[125I]leptin to rat kidney medullary membranes was time-de-
pendent (ti/2 - 15 ± 5; n - 3) and reached an apparent equili-
brium in about 60 min (A:obs = 0.055 ± 0.008 min- 1). After 90 
min of incubation, the binding of [125I]leptin was reversed by 
the addition of unlabeled leptin (1 uM) to the assay. Dissoci-
ation of the leptin-receptor complex (Fig. 1) occurred slowly 
with an apparent dissociation constant (K-i) value of 
0.048 ±0.012 min- 1 . However, the process seemed to be bi-
phasic since after 5.5 h in the presence of 1 |tM cold leptin, 
the dissociation was not total and reached 80%. From the 
kinetic experiments, a calculated K^ value of 0.5 nM was 
obtained. After equilibrium, under standard conditions, non-
specific binding represented about 30% of total binding. 
Saturation experiments indicated that the specific binding 
was saturable (Fig. 2A). Scatchard analysis of these data (Fig. 
2B) gave a linear plot consistent with the presence of a single 
class of high-affinity binding sites characterized by an appa-
rent Kd of 0.57 ±0.14 nM and a maximal binding capacity 
(Bmax) of 43 ± 10 fmol/mg protein (« = 4). 
As shown in Fig. 3, [125I]leptin binding was inhibited in a 
dose-dependent manner by unlabeled leptin with an IC50 val-
ue of 0.72 ± 0.19 nM (n = 5) and a pseudo Hill coefficient («H) 
about unit («H = 0.99 ±0.15, n = 5) consistent with competitive 
antagonism. It was interesting to note that the K^ value ob-
tained from Scatchard plot was consistent with those obtained 
from kinetic and competition experiments. 
Moreover, binding of [125I]leptin was highly specific since 
various seven transmembrane G-protein-coupled receptor 
peptides (neuropeptide Y, peptide YY, pancreatic polypep-
tide, cholecystokinin, endothelin, neurotensin, corticotropin 
releasing factor, vasopressin, oxytocin, 1 u.M) and several 
closely related cytokine receptor factors (0.2 ug/ml IL-6, 0.5 
|j,g/ml leukemia inhibitory factor, 100 uM insulin and 0.25 (tg/ 
1500 
E 
a. 
■o 
O 1 0 0 0 -
z 
a: 500 o 
O 
LLI 
a. 
120 180 240 
TIME (min) 
360 
Fig. 1. Time-course of association (•) and dissociation (o) of 
[125I]leptin to rat kidney medullary membranes. Incubations were 
carried out as described in Section 2 in the presence of 55 pM 
[125I]leptin for various periods of time. Arrow indicates time (90 
min) at which cold leptin (1 u.M) was added to initiate the dissocia-
tion process. Results represent data from a typical experiment per-
formed in duplicate and repeated 3 times without noticeable modifi-
cations. 
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Fig. 2. Saturation of [126I]leptin specific binding to rat kidney medullary membranes. A: Saturation isotherm; B: Scatchard plot. Data are 
means calculated from a typical experiment performed in duplicate and repeated 4 times without noticeable changes. 
ml granulocyte-colony stimulating factor) were unable to in-
hibit [125I]leptin specific binding to rat kidney membranes. 
3.2. Autoradiographic distribution of leptin binding sites in the 
rat kidney 
In the adult (60 days old) rat kidney, [125I]leptin intensely 
labeled the medullary region whereas an absence of labeling 
was observed in renal cortex, outer stripe and extremity of 
papilla (Fig. 4A) showing that no binding sites were evidenced 
on renal structures such as the glomeruli, proximal and distal 
tubules, and terminal collecting ducts. 
In the medullary area two types of labeling were shown. We 
observed massive central labeling with [125I]leptin in the inner 
medulla region which spread from inner medulla to inner 
stripe of outer medulla as radiating streaks. This pattern is 
consistent with labeling associated with vascular structures 
such as vasa recta and/or descending thin Henle's limbs be-
longing to both short and long looped-nephrons. [125I]leptin 
showed also consistent binding to the renal pelvic wall, an 
epithelium structure which delineates the papillary surface 
and which corresponds to a remmant of capsula fibrosa. 
Finally, it is important to note sparse individual spots of 
[125I]leptin localized in the renal cortico-medullary area, prob-
ably corresponding to the wall of big blood vessels cut in this 
region which could be an association of arterial and vein as 
observed under microscope (not shown). The association of 
[125I]leptin to vessels was clearly evidenced in autoradiograms 
performed in transversal rat kidney sections at the level of the 
medullary region (Fig. 4B). 
3.3. Renal developmental expression of [125IJleptin binding 
sites 
Expression of [125I]leptin binding sites was visualized in the 
kidney of developing (8-30 days old) and adult (60 and 84 
days old) rats by autoradiography (Fig. 5). In contrast to a 
number of other organs, the kidney is not morphologically 
and functionnally fully differentiated until about day 60, re-
ferred to the adult period [21,22]. Although the autoradio-
graphic techniques used did not allow localization at the cel-
lular level, this study provided further evidence that 
[125I]leptin labeling was firstly age-dependent and secondly 
was mainly associated with medulla from the 21-30-day 
post-natal period. The labeling was emphasized in this latter 
anatomic structure at adult stages (Fig. 5C,D). At the earliest 
developmental stage investigated, 8 days, specific [125I]leptin 
labeling was almost undetectable in the kidney except in a 
discrete area of the medullary region (Fig. 5A). There was 
also little expression of leptin binding sites in the 21-day-old 
rat kidney; however, a general mapping of the medullary 
region appeared at this stage (Fig. 5B). The density of leptin 
binding sites to individual anatomic structures of the kidney 
was markedly increased between 21 and 30 days (Fig. 5C) and 
was concentrated in the central medulla. This mapping re-
mained stable through adulthood and has a similar profile 
to that observed at 60 days (Fig. 4) and up to 84 days (Fig. 
5D). 
3.4. Effect of leptin on diuresis in conscious Sprague-Dawley 
rats 
A preliminary set of experiments was performed in water-
loaded rats to investigate potential antidiuretic properties for 
leptin. In this model, vasopressin levels are presumably very 
low [23] and diuresis sufficiently high to detect any antidiuretic 
component. As shown in Table 1, leptin (1 mg/kg i.p.) had no 
influence on urine volume within the 6-h observation period 
and no potential antidiuretic action was detected. 
On the other hand, as shown in Fig. 6, acute administration 
of leptin (0.5 mg/kg i.p.) significantly increased urine excretion 
during the first-hour collection period in normally hydrated 
conscious rats. The time-course study showed a consistent and 
rapid diuretic effect of leptin on urine flow rate that was 
highly significant at 0.5 h. This effect disappeared within 2 h 
after the administration of leptin. As a consequence of the 
diuretic effect obtained, a significant ( P < 0.001) decrease in 
urine excretion latency was observed for the leptin-treated 
group (i.e. 60% of the leptin-treated animals had their first 
miction at 0.5 h whereas the same proportion was reached 
after 3 h in the control group). Leptin also lowered signifi-
cantly (P<0.05) urine osmolality only in the first 2-h period: 
757 ±50 mOsm/kg H 2 0 (« = 7) and 479 ±53 mOsm/kg H 2 0 
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Fig. 3. Inhibition of specific [126I]leptin binding to rat kidney medul-
lary membranes by increasing concentrations of unlabeled leptin. In-
cubations were carried out with about 60 pM [125I]leptin for 90 min 
at room temperature. Data are means calculated from a typical ex-
periment performed in duplicate and repeated 5 times without no-
ticeable changes. 
(»= 15) for the control and leptin-treated group, respectively. 
It is important to note that control parameter values observed 
in these studies are comparable to those previously described 
by ourselves and others [24,25]. 
4. Discussion 
The present study demonstrates that the mature rat kidney 
expresses high-affinity binding sites for [125I]leptin with intense 
localization in the medullary region. High levels of expression 
(A) 
occurred only in advanced postnatal developing stages and in 
the adult kidney. In addition, our data show that this hor-
mone may play a direct role on this organ by inducing a 
significant diuretic effect after administration in vivo. 
Widespread distribution of mRNA of several leptin recep-
tor isoforms has been reported in several peripheral organs 
from mice, rat and human showing that this new hormone, 
besides having central effects, could have a pleiotropic action 
[26]. But up to now, only the leptin receptors of the choroid 
plexus and the hypothalamus have been further documented 
in terms of expression, binding affinity constants and mapping 
[5,11,27,28]. Here, we report the direct characterization and 
localization of leptin receptors in a target organ such as the 
kidney using [125I]leptin as a ligand. Full identification of lep-
tin receptors has been performed by in vitro binding of 
[125I]leptin to rat renomedullary membranes and autoradiog-
raphy on rat kidney sections demonstrating a preferential lo-
calization of leptin sites in the specific area of the inner me-
dulla. 
Binding of [125I]leptin to rat renomedullary membranes 
showed high-affinity, specificity and saturability and was 
time-dependent. Dissociation of [125I]leptin by unlabeled lep-
tin occurred slowly and was not total after 4 h, suggesting a 
tight association of leptin to its sites. A single class of high-
affinity binding sites with a K& of 0.57 ±0.14 nM and a max-
imal capacity (Bmax) of 45 ±10 fmol/mg protein (« = 4) was 
identified. Similar affinity was reported for murine choroid 
plexus leptin receptors transfected in COS cells (X<j value of 
0.7 nM) [11] and in ob/ob mice choroid plexus (IC50 value of 
1-2 nM) as determined by Lynn et al. [27]. In contrast, lower 
affinity was found for [125I]leptin in purified hypothalamic ob/ 
ob mice plasma membranes (IC50 = 46 nM) together with a 
(B) 
5 mm 
Fig. 4. Localization of [125I]leptin binding sites in adult (60-day-old) rat kidney sections. Autoradiograms were obtained from (A) longitudinal 
or (B) transversal rat kidney sections incubated in the presence of 40 pM [125I]leptin. Non-specific (NS) binding was obtained from the adjacent 
section by incubating in the presence of 0.3 uM unlabeled leptin. Calibration bar: 5 mm. 
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Fig. 5. Postnatal developmental expression of [125I]leptin binding sites in the rat kidney. Autoradiograms were obtained from longitudinal kid-
ney sections from 8-day (A), 21-day (B), 30-day (C) and 84-day-old (D) male Sprague-Dawley rats as described in Section 2. Each non-specific 
(NS) binding was obtained by incubating the adjacent section in the presence of 0.3 uM unlabeled leptin. Calibration bar: 5 mm. 
200-fold higher density of binding sites than that observed in 
our crude rat kidney preparations [5]. mRNA of a number of 
leptin receptor isoforms, with a different pattern of tissue ex-
pression, have been identified and seem highly conserved 
among species, including man [29]. A long isoform (ob-Rb, 
reported as the functional receptor) is preferentially expressed 
in the hypothalamus whereas short isoforms ob-Ra, ob-Rc, 
ob-Rd, ob-Re and rat-ob-Rf have selective expression in a 
wide variety of peripheral organs including the kidney [10-
14,30]. Thus, it is tempting to speculate that the different 
leptin receptor isoforms could have different affinities for the 
natural hormone yielding different affinity for leptin in hypo-
thalamus and in choroid plexus (or kidney). However, this 
explanation must be considered premature since so far only 
few binding data are available and different operating condi-
tions could influence binding parameter determination. In ad-
dition, a recent study using [35S]leptin as a probe reported 
equally potent binding in the choroid plexus from wild-type 
or leptin receptor-defective animals (db/db mice or Zucker 
rats) showing that the lack of response to leptin is not due 
to a deficiency in leptin binding but to an abnormality rather 
occurring at a site downstream from receptor binding [9]. 
Concerning detailed anatomic localization of leptin recep-
tors in mature rat kidney, we observed that the inner medul-
lary region bears the most abundant labeling, using macro-
scopic autoradiography. Although this technique did not 
allow localization at the cellular level, the distribution profile 
is consistent with labeling associated to vascular bundles, vasa 
recta and/or functional elements of the nephron such as the 
thin descending Henle's limb belonging to short and long-
looped nephrons specific to the rat kidney anatomy. We can-
not exclude the possibility of labeling in renomedullary inter-
Table 1 
Effect of acute administration of leptin (1 mg/kg i.p.) on urine excretion in adult water-loaded Sprague-Dawley rats 
Time Cumulated urine volume (ml) 
(h) 0.5 1 2 4 
Control 
Leptin 
0.91 ±0.33 
1.44 ±0.30 
3.05±0.31 
3.14 ±0.26 
3.62 ±0.45 
3.52 ±0.22 
3.86 ±0.39 
3.16±0.33 
4.5 ±0.48 
5.00 ±0.35 
Each group of rats were treated either with leptin or vehicle (bidistilled water, 1 ml/kg) just after receiving by gavage a water load of 25 mg/kg. 
Cumulated urine volume was measured at the different times. Result are means ± SEM of seven determinations. 
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Fig. 6. Time-course effect of leptin on urine volume in normally hydrated rats. Each group of male Sprague-Dawley rats was treated either 
with leptin (0.5 mg/kg i.p.) or vehicle (bidistilled water, 1 ml/kg). Urine was collected throughout the 6-h period after treatment with individual 
measures of urine volume at 0.5, 1, 2, 4 and 6 h. Values are means! SEM of 19 determinations per group. Drug and control groups were com-
pared by a Mann-Whittney test, corrected by Bonferroni for repeated measures: *P<0.05, **P<0.01. 
stitial cells of the inner medulla. No leptin sites are evidenced, 
or are too scarce to be detected, in glomeruli, proximal and 
distal tubules and terminal collecting ducts. It is worth noting 
that vascular elements of the kidney also are a target system 
for interacting with leptin since the walls of big vessels of the 
cortico-medullary area are intensely labeled by [125I]leptin. 
Even if up to now no major effect of leptin has been reported 
on arterial blood pressure (up to 1 mg/kg after i.v. adminis-
tration in anaesthetized rats, not shown), specific association 
of [125I]leptin to vascular structures has been reported in brain 
pia mater vessels from lean and obese Zucker rats [28]. 
After birth, we observed a gradual expression of renal leptin 
receptors as a function of maturation of this organ. Absent at 
early postnatal ages (8-21 days), full expression occurred after 
about 30 days and remained constant throughout adulthood, 
showing that an unknown induction mechanism regulates the 
plasticity of renal leptin receptors (hormones, growth factors, 
circulating leptin, etc.). Since several leptin receptor isoform 
mRNA coexist in the kidney (in particular, the mRNA of the 
two short isoforms ob-Ra ob-Rf are relatively abundant) [10-
14,30], the individual postnatal developmental expression of 
each of them needs to be further explored by molecular biol-
ogy. Up to now, no studies providing a detailed localization 
of the different mRNA isoforms are available and precludes 
any comparison between messenger distribution and receptor 
expression in the kidney. A comparative study in mice and 
man has shown that expression levels of the new isoform 
B219/ob-R in adult tissues are species specific and have lower 
expression in the whole adult human kidney than at fetal age. 
Obviously, differences in the pattern of tissue expression of 
receptor isoforms may reflect differences in their function. 
Consistent with the presence of leptin receptors in the re-
nomedullary region, we observed a significant diuretic effect 
lasting about 2 h at 0.5 mg/kg i.p., associated with a marked 
decrease in urine osmolality after in vivo leptin administration 
to mature normally hydrated conscious rats. Thus, we showed 
here that leptin, mainly known as a satiety factor, could have 
a functional significance in the kidney in vivo after systemic 
administration. Our results are in agreement with a recent 
abstract published during the preparation of this manuscript 
reporting a diuretic effect of leptin after direct infusion into 
the renal artery in anesthetized rats [31]. We can assume that 
leptin could act directly via leptin receptors present in the area 
of renal medulla but a role in concert with other hormones 
cannot be excluded. 
Thus, the functional role of leptin now appears to extend 
beyond the regulation of feeding behavior and metabolism to 
include other organs and biological functions (hematopoiesis, 
fertility, circadian rhythms, etc.). Two recent major observa-
tions show that leptin exerts a powerful stimulatory effect on 
the reproductive system and reverses the effects of fasting on 
other endocrine systems [12,32-34]. These findings are of in-
terest since leptin plasma levels are submitted to fluctuation 
according to gender, age, circadian rythm, and are markedly 
increased in various disorders such as obesity and in hemo-
dialysis patients [7,35-38]. Moreover, it has been recently 
demonstrated that in lean subjects the circulating leptin is in 
protein bound form (among them the ob-Re soluble receptor 
isoform) subsequently not available for receptors, whereas in 
obese subjects, this hormone circulates mainly in a free form, 
corresponding presumably to the bioactive protein [39]. In this 
latter situation, we can assume that leptin could easily bind to 
target peripheral sites (i.e. in the kidney) and induce a poten-
tial biological effect or simply could be uptaken for clearance 
from the circulation. 
In conclusion, we report here the presence and the charac-
terization of high-affinity binding sites for leptin in the mature 
rat kidney, especially localized in the renomedullary region. 
The pattern of developmental plasticity showed that at adult 
and postnatal pre-adult ages high amounts of leptin receptors 
are expressed in this organ and could mediate the diuretic 
effect observed for leptin. However, the relationship between 
the appearance of renal leptin receptors and which isoforms, 
their linkage to the second messenger system, their function, 
circulating leptin levels and diuretic effect need to be further 
explored. 
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